rs190648042

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2

The NM_001122681.2(SH3BP2):​c.1686A>G​(p.Ter562Trpext*?) variant causes a stop lost change. The variant allele was found at a frequency of 0.000812 in 1,563,928 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00070 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

SH3BP2
NM_001122681.2 stop_lost

Scores

2
1
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: 6.39

Publications

5 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Stoplost variant in NM_001122681.2 Downstream stopcodon found after 580 codons.
BP6
Variant 4-2833834-A-G is Benign according to our data. Variant chr4-2833834-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 525208.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000696 (106/152288) while in subpopulation NFE AF = 0.00109 (74/68020). AF 95% confidence interval is 0.000888. There are 1 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 106 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.1686A>G p.Ter562Trpext*? stop_lost Exon 13 of 13 ENST00000503393.8 NP_001116153.1 P78314-1A0A384N6E5
SH3BP2NM_001145856.2 linkc.1857A>G p.Ter619Trpext*? stop_lost Exon 13 of 13 NP_001139328.1 P78314-4
SH3BP2NM_001145855.2 linkc.1770A>G p.Ter590Trpext*? stop_lost Exon 13 of 13 NP_001139327.1 P78314-3
SH3BP2NM_003023.4 linkc.1686A>G p.Ter562Trpext*? stop_lost Exon 13 of 13 NP_003014.3 P78314-1A0A384N6E5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.1686A>G p.Ter562Trpext*? stop_lost Exon 13 of 13 1 NM_001122681.2 ENSP00000422168.3 P78314-1

Frequencies

GnomAD3 genomes
AF:
0.000697
AC:
106
AN:
152170
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00109
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000583
AC:
102
AN:
175060
AF XY:
0.000585
show subpopulations
Gnomad AFR exome
AF:
0.000380
Gnomad AMR exome
AF:
0.0000740
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00296
Gnomad NFE exome
AF:
0.000704
Gnomad OTH exome
AF:
0.000836
GnomAD4 exome
AF:
0.000825
AC:
1164
AN:
1411640
Hom.:
1
Cov.:
31
AF XY:
0.000791
AC XY:
552
AN XY:
698222
show subpopulations
African (AFR)
AF:
0.000155
AC:
5
AN:
32360
American (AMR)
AF:
0.0000781
AC:
3
AN:
38388
Ashkenazi Jewish (ASJ)
AF:
0.0000394
AC:
1
AN:
25380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37056
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81270
European-Finnish (FIN)
AF:
0.00317
AC:
146
AN:
46060
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5244
European-Non Finnish (NFE)
AF:
0.000899
AC:
978
AN:
1087384
Other (OTH)
AF:
0.000530
AC:
31
AN:
58498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000696
AC:
106
AN:
152288
Hom.:
1
Cov.:
33
AF XY:
0.000739
AC XY:
55
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41554
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00109
AC:
74
AN:
68020
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000893
Hom.:
1
Bravo
AF:
0.000446
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000438
AC:
52
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fibrous dysplasia of jaw Benign:3
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
17
DANN
Benign
0.83
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.97
D
PhyloP100
6.4
Vest4
0.24
GERP RS
5.6
Mutation Taster
=200/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190648042; hg19: chr4-2835561; API